ArticleFrontiers in molecular biosciences2021

A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients.

Meera Shanmuganathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.